ARCHIVES

ODAC Meeting: Further Restrictions Likely On ESA Use; Changes Advocated by ODAC May Cut Market By 40-50 Percent.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

High Dose Chemotherapy Significantly Prolongs Survival In ECOG Clinical Trial

November 28, 2008

AACR Journal Publishes a Henschke Letter Without Disclosure of Conflicts.

April 25, 2008

In Brief: ACS Awards Professorship To Bernstein; HCFA Clears Dana-Farber For Medicare

August 11, 1995

Fountain Hearings Turn Up Some Responsible Criticism, some Not, Much Support for Program

June 24, 1977

House Committee To Examine Personal Genetic Test Kits

May 21, 2010

Conversation with TCL:Demetri: Morcellation Worsens Outcomes In Patients with Undiagnosed Cancers

November 21, 2014